| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 815.77B | 808.93B | 801.02B | 784.97B | 320.87B | 315.38B |
| Gross Profit | 247.10B | 232.55B | 237.06B | 231.22B | 90.15B | 88.18B |
| EBITDA | 24.70B | 24.89B | 29.94B | 31.41B | 13.61B | 13.64B |
| Net Income | 3.94B | 3.82B | 7.44B | 9.03B | 3.94B | 4.18B |
Balance Sheet | ||||||
| Total Assets | 435.36B | 411.81B | 427.70B | 431.32B | 174.97B | 181.07B |
| Cash, Cash Equivalents and Short-Term Investments | 38.48B | 26.29B | 37.18B | 31.80B | 12.50B | 13.06B |
| Total Debt | 54.36B | 69.83B | 81.05B | 88.67B | 29.39B | 30.19B |
| Total Liabilities | 215.60B | 193.77B | 211.61B | 221.93B | 79.64B | 87.15B |
| Stockholders Equity | 219.48B | 217.76B | 215.84B | 209.14B | 95.10B | 93.69B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -41.00M | 14.69B | 3.08B | 1.86B | 6.80B |
| Operating Cash Flow | 0.00 | 16.75B | 30.61B | 24.16B | 8.63B | 12.60B |
| Investing Cash Flow | 0.00 | -12.97B | -14.61B | -14.52B | -6.48B | -8.28B |
| Financing Cash Flow | 0.00 | -14.67B | -10.62B | -5.41B | -2.71B | -1.84B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥179.63B | 11.59 | ― | 2.18% | 6.30% | 27.88% | |
73 Outperform | ¥189.58B | 16.36 | 7.56% | 2.70% | 2.28% | 3.61% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | ¥178.66B | 46.86 | ― | 1.44% | 1.48% | -33.32% | |
61 Neutral | ¥215.86B | 18.12 | ― | 3.01% | 18.89% | -34.43% | |
56 Neutral | ¥127.52B | 35.48 | ― | 1.77% | 8.65% | -45.94% | |
53 Neutral | ¥174.08B | 87.68 | ― | 1.77% | 30.67% | ― |
Fuji Co., Ltd. has revised its full-year consolidated earnings forecast for the fiscal year ending February 2026, trimming operating revenue slightly to ¥814 billion and sharply lowering projections for operating and ordinary profit, while modestly increasing its net profit outlook. Despite steady sales in food products supported by low-price strategies, value-added offerings, and efforts to revitalize existing stores, profits are being squeezed by higher labor, logistics, and maintenance costs, leading to an expected decline in operating and ordinary income versus the previous forecast, though extraordinary gains from the sale of investment securities and asset portfolio adjustments are expected to lift net profit above prior guidance, with no change to the planned year-end dividend.
The most recent analyst rating on (JP:8278) stock is a Hold with a Yen2129.00 price target. To see the full list of analyst forecasts on Fuji Co., Ltd. stock, see the JP:8278 Stock Forecast page.
Fuji Co., Ltd. has completed the transfer of all its shares in Lady Drug Store Co., Ltd., an equity-method affiliate, and will book substantial extraordinary gains from the divestment in its results for the fiscal year ending February 2026. The company expects to record an 8,189 million yen gain on sale of investment securities in its consolidated fourth-quarter results and a 17,447 million yen gain on sale of affiliated company shares in its non-consolidated accounts, with the impact already incorporated into its latest consolidated earnings forecast, signaling a notable one-off profit boost that may strengthen its financial position and capital allocation flexibility.
The most recent analyst rating on (JP:8278) stock is a Hold with a Yen2129.00 price target. To see the full list of analyst forecasts on Fuji Co., Ltd. stock, see the JP:8278 Stock Forecast page.
Fuji Co., Ltd. reported consolidated operating revenue of ¥605.9 billion for the nine months ended November 30, 2025, up 1.3% year on year, but operating profit and ordinary profit declined 21.4% and 19.1%, respectively, with profit attributable to owners of parent essentially flat at ¥3.1 billion and basic earnings per share edging down to ¥35.72. Despite a slight increase in total assets to ¥426.9 billion and a marginal rise in equity, the equity ratio eased to 51.1%, and management kept its dividend policy unchanged, maintaining a full‑year payout forecast of ¥30 per share; for the full fiscal year ending February 28, 2026, the company now forecasts modest top-line growth but double-digit declines in operating and ordinary profit, while expecting a strong rebound in full‑year net profit, implying continued emphasis on shareholder returns amid profit margin pressure and a challenging operating environment.
The most recent analyst rating on (JP:8278) stock is a Hold with a Yen2129.00 price target. To see the full list of analyst forecasts on Fuji Co., Ltd. stock, see the JP:8278 Stock Forecast page.
Fuji Co., Ltd. has announced its decision to transfer its 49% stake in Lady Drug Store Co., Ltd. to Tsuruha Holdings Inc. and through a share buyback by Lady. This strategic move is aimed at enhancing Fuji’s corporate value by utilizing the proceeds to support its medium-term management plan and strengthen its financial foundation. Despite the divestment, Fuji plans to maintain cooperative relations with Lady as both companies are part of the AEON group, which is expected to consolidate Tsuruha as a subsidiary. This decision comes amid increasing competition in the drugstore industry and Tsuruha’s goal to accelerate decision-making and investments by making Lady a wholly owned subsidiary.
The most recent analyst rating on (JP:8278) stock is a Hold with a Yen2129.00 price target. To see the full list of analyst forecasts on Fuji Co., Ltd. stock, see the JP:8278 Stock Forecast page.
Fuji Co., Ltd. announced the sale of its shares in AEON Kyushu Co., Ltd., participating in a secondary offering as a selling shareholder. This transaction is expected to result in an extraordinary income of 1,273 million yen, impacting the company’s consolidated financial results positively for the third quarter of the fiscal year ending February 28, 2026.
The most recent analyst rating on (JP:8278) stock is a Hold with a Yen2129.00 price target. To see the full list of analyst forecasts on Fuji Co., Ltd. stock, see the JP:8278 Stock Forecast page.
Fuji Co., Ltd. has announced its participation in the secondary offering of common shares of Aeon Kyushu Co., Ltd. by selling all its shares in the company. This decision is aimed at improving capital efficiency and strengthening Fuji’s financial base, with the impact on financial results to be disclosed after the sale price is determined.
The most recent analyst rating on (JP:8278) stock is a Hold with a Yen2129.00 price target. To see the full list of analyst forecasts on Fuji Co., Ltd. stock, see the JP:8278 Stock Forecast page.